Skip to main content
Home
language-selector-globe Korea | ko
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Korea
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      About Novartis Korea 회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      A couple holding hands 환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      Novartis Health Care 의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation 혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      Novartis ESG 환경, 사회 및 가브넌스
    • 뉴스룸 
      • 보도자료  
      • 이노베이션 스토리  
      • 자료실 
        • 의약품 회수에 관한 공표 
      Novartis News 뉴스룸
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      Novartis Careers 인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1 코로나바이러스감염증-19 (COVID-19) 업데이트
    Seoul Skyline Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title
  • Site Sort descending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort descending Location Division Business Functional Area Date Posted
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior Manager - Direct tax Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 10, 2024
Medical Lead Oncology Mumbai (Head Office) India International Innovative Medicines Research & Development Sep 16, 2024
Regional Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Sep 27, 2024
Zonal Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Oct 01, 2024
Global GMP Expert Quality Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Oct 07, 2024
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 14, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Sep 09, 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Associate Director- Clinical Data Standards Mumbai (Office) India Development Innovative Medicines Research & Development Sep 13, 2024
Lead Principal CDS Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Sep 15, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 16, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Oct 18, 2024
Sachkundige Person Radiopharmazie (d/w/m) Munich (AAA Germany GmbH) Germany Operations Innovative Medicines Quality Apr 22, 2024
Omnichannel Engagement Manager (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Jul 10, 2024
Content Healthcare Manager (m/w/d) in Voll- und Teilzeit Munich (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Oct 14, 2024
Field Force Execution Lead (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Sep 19, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Production Technician Murcia Spain Operations Innovative Medicines Technical Operations Oct 07, 2024
Quality Assurance Specialist Murcia Spain Operations Innovative Medicines Quality Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
SALES Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 15, 2024
(高级)医药代表 /(资深)产品专员 Nanyang (Henan Province) China International Innovative Medicines Sales Aug 23, 2024
县域主任(主管) Nanyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Oct 18, 2024
Pricing Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Jul 31, 2024
Head of Data Driven Decision Making New South Wales (NSW) Australia International Innovative Medicines Marketing Sep 19, 2024
Senior Market Access Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Sep 30, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Oct 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 42
  • › Next page

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 가브넌스
  • 뉴스룸
  • 인재채용
Media Center
  • 보도자료
  • 이노베이션 스토리
Other Novartis Websites in Korea
  • MedHub
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2024 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431